Skip to main content
SpringerLink
Log in

Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2

  • Original Article
  • Published:
European Spine Journal Aims and scope Submit manuscript

Abstract

The use of bone morphogenetic protein-2 (rhBMP-2) in spinal fusion has increased dramatically since an FDA approval for its use in anterior lumbar fusion with the LT cage. There are several reports of its use in transforaminal lumbar interbody fusion, posterolateral fusion, and anterior cervical fusion. Reports on adverse effects of rhBMP-2 when used in spinal fusion are scarce in literature. An Institutional Review Board approved retrospective study was conducted in patients undergoing anterior spinal fusion and instrumentation following diskectomy at a single center. Forty-six consecutive patients were included. Twenty-two patients treated with rhBMP-2 and PEEK cages were compared to 24 in whom allograft spacers and demineralized bone matrix was used. Patients filled out Cervical Oswestry Scores, VAS for arm pain, neck pain, and had radiographs preoperatively as well at every follow up visit. Radiographic examination following surgery revealed end plate resorption in all patients in whom rhBMP-2 was used. This was followed by a period of new bone formation commencing at 6 weeks. In contrast, allograft patients showed a progressive blurring of end plate-allograft junction. Dysphagia was a common complication and it was significantly more frequent and more severe in patients in whom rhBMP-2 was used. Post operative swelling anterior to the vertebral body on lateral cervical spine X-ray was significantly larger in the rhBMP-2 group when measured from 1 to 6 weeks after which it was similar. These effects are possibly due to an early inflammatory response to rhBMP-2 and were observed to be dose related. With the parameters we used, there was no significant difference in the clinical outcome of patients in the two groups at 2 years. The cost of implants in patients treated with rhBMP-2 and PEEK spacers was more than three times the cost of allograft spacers and demineralized bone matrix in 1, 2, and 3-level cases. Despite providing consistently good fusion rates, we have abandoned using rhBMP-2 and PEEK cages for anterior cervical fusion, due to the side effects, high cost, and the availability of a suitable alternative.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. A guide from the The American Academy of Orthopedic Surgeons (AAOS) and American Association of Tissue Banks (AATB): What can you tell me about bone and tissue transplantation. Retrieved June 21, 2005 from http://www.aatb.org/aaosinfo.htm

  2. Baskin DS, Ryan P, Sonntag V, Westmark R, Widmayer MA (2003) A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SRTM allograft ring and the ATLANTISTM anterior cervical plate. Spine 28(12):1219–1224

    Article  PubMed  Google Scholar 

  3. Boakye M, Mummaneni PV, Garrett M, Rodts G, Haid R (2005) Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. J Neurosurg Spine 2:521–525

    PubMed  Google Scholar 

  4. Boden SD, Kang J, Sandhu H, Heller JG (2002) Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, Randomized clinical pilot trial 2002 Volvo Award in clinical studies. Spine 27(23):2662–2673

    Article  PubMed  Google Scholar 

  5. Burkus JK (2004) Bone morphogenetic proteins in anterior lumbar interbody fusion: old techniques and new technologies. J Neurosurg Spine 3:254–260

    Google Scholar 

  6. Burkus JK, Heim SE, Gornet MF, Zdeblick TA (2004) The effectiveness of rhBMP-2 in replacing autograft: an integrated analysis of three human spine studies. Orthopedics 27(7):723–728

    PubMed  Google Scholar 

  7. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM (1990) Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 87(24):9843–9847

    Article  PubMed  CAS  Google Scholar 

  8. Hidehiro I, Sohei E, Mikio K, Yutaka T, Tetsuya K, Yohei Y, Kunio T (1999) Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2. Spine 24(14):1402–1405

    Article  Google Scholar 

  9. Johnson EE, Urist MR, Finerman GAM (1988) Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. Clin Orthop Relat Res 230:257–265

    PubMed  Google Scholar 

  10. Johnson EE, Urist MR, Finerman GA (1988) Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report. Clin Orthop Relat Res 236:249–257

    PubMed  Google Scholar 

  11. Kleeman TJ, Michael Ahn U, Talbot-Kleeman A (2001) Laparoscopic anterior lumbar interbody fusion with rhBMP-2: a prospective study of clinical and radiographic outcomes. Spine 26(24):2751–2756

    Article  PubMed  CAS  Google Scholar 

  12. Mummaneni PV, Pan J, Haid RW, Rodts GE (2004) Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion. J Neurosurg Spine 1:19–23

    Article  PubMed  Google Scholar 

  13. Poynton AR, Lane JM (2002) Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 27(16S):S40–S48

    Article  PubMed  Google Scholar 

  14. Sandhu HS (2003). Bone morphogenetic proteins and spinal surgery. Spine 28(15S):S64–S73

    Article  PubMed  Google Scholar 

  15. Sandhu HS, Khan SN (2003) Recombinant human bone morphogenetic protein-2: use in spinal fusion applications. J Bone Joint Surg 85-A(Suppl 3):89–95

    PubMed  Google Scholar 

  16. Sandhu HS, Toth JM, Diwan AD, Seim HB, Kanim LEA, Kabo JM, Turner AS (2002) Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion. Spine 27(6):567–575

    Article  PubMed  Google Scholar 

  17. Schimandle JH, Boden SD, Hutton WC (1995) Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 20(12):1326–1337

    Article  PubMed  CAS  Google Scholar 

  18. Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, Shields CB (2006) Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 31(5):542–547

    Article  PubMed  Google Scholar 

  19. Ullrich PF (1999) Anterior cervical spinal fusion surgery. Retrieved June 21, 2005 from http://www.spine-health.com/topics/surg/overview/cervical/cerv03.html

  20. Urist MR (1965) Bone: formation by autoinduction. Science 150:893–899

    Article  PubMed  CAS  Google Scholar 

  21. Wang EA, Rosen V, D’Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P et al (1990) Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87(6):2220–2224

    Article  PubMed  CAS  Google Scholar 

  22. Wang EA, Rosen V, Cordes P, Hewick RM, Kriz MJ, Luxenberg DP, Sibley BS, Wozney JM (1988) Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA 85(24):9484–9488

    Article  PubMed  CAS  Google Scholar 

  23. Zdeblick TA, Ghanayem AJ, Rapoff AJ, Swain C, Bassett T, Cooke ME, Markel M (1998) Cervical interbody fusion cages: an animal model with and without bone morphogenetic protein. Spine 23(7):758–765

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopedics, Detroit Receiving Hospital, University Health Center, 4201 St. Antoine Boulevard 6A, Detroit, MI, 48201, USA

    Rahul Vaidya & Anil Sethi

  2. Department of Orthopedics, Henry Ford Hospital, 2799 West Grand Boulevard K-12, Detroit, MI, 48202, USA

    Julia Carp, Stephen Bartol & Clifford M. Les

  3. Department of Radiology, Henry Ford Hospital, 2799 West Grand Boulevard K-12, Detroit, MI, 48202, USA

    Joseph Craig

Authors
  1. Rahul Vaidya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julia Carp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anil Sethi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stephen Bartol
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joseph Craig
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Clifford M. Les
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rahul Vaidya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vaidya, R., Carp, J., Sethi, A. et al. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2. Eur Spine J 16, 1257–1265 (2007). https://doi.org/10.1007/s00586-007-0351-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00586-007-0351-9

Keywords

Search

Navigation